Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glimepiride (3mg) Tablet
Therapeutic Category
Antidiabetic, Diabetic, Endocrinology
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹0/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Glibclay 3 Tablet contains Glimepiride 3mg, a potent sulfonylurea used to improve glycemic control in patients with type-2 diabetes mellitus. It is effective in stimulating pancreatic insulin secretion and maintaining blood sugar levels within target ranges.
Glimepiride works by enhancing endogenous insulin release in response to elevated blood glucose, helping regulate both fasting and postprandial blood sugar levels. Its oral administration and once-daily dosing support patient adherence in long-term therapy.
This medicine is ideal for patients inadequately controlled on diet and exercise alone, offering reliable efficacy and a favorable safety profile. Its clinical use spans outpatient and hospital-based diabetes management programs.
Adding Glibclay 3 Tablet to your diabetes and metabolic-care portfolio strengthens your product offerings, creating strong opportunities in retail pharmacies, hospital supply, institutional distribution, export markets, and third-party manufacturing. Its high prescription rate ensures consistent demand and commercial viability.
Some patients may experience hypoglycemia, dizziness, nausea, or mild gastrointestinal discomfort. Rarely, allergic reactions, weight gain, or hematologic abnormalities may occur.
Glibclay 3 Tablet is indicated for the management of type 2 diabetes mellitus in patients whose blood sugar levels are not adequately controlled by diet and exercise alone. It helps improve glycemic control and reduce fasting and postprandial blood glucose levels.
Use strictly under medical supervision. Regular monitoring of blood glucose is recommended to prevent hypoglycemia. Avoid use in patients with severe renal or hepatic impairment. Follow the prescribed dosage and lifestyle modifications carefully.
Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.
Composition : Calcium Dobesilate Monohydrate I.P. 500 mg Capsule
Composition : L-Arginine (3gm) + Proanthocyanidin (75mg) sachet
Composition : Aminacrine HCl 0.1g + Cetrimide Cream 0.5g
Composition : Chlorhexidine Gluconate (0.20% w/w) + Silver Nitrate (0.20% w/w) cream
Composition : Hydroquinone (2% w/w) + Mometasone (0.1% w/w) + Tretinoin (0.025% w/w)
Composition : Fusidic Acid I.P. 2.00% w/w + Beclomethasone Dipropionate I.P. 0.025% w/w
Composition : Cranberry Extract 300mg + D-Mannose 600mg Tablet
Composition : Terbinafine (1% w/w)
Composition : Tretinoin 0.05% Cream
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Glimepiride 3mg Tablet is an oral anti-diabetic medicine used in type 2 diabetes management, making it a strong prescription product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in type 2 diabetes, fasting blood sugar control, insulin resistance management, and long-term glycemic control. It is widely prescribed by physicians and diabetologists as part of step-up therapy when lower doses are insufficient.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Glimepiride 3mg Tablet with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady chronic prescription demand, long-term diabetes therapy usage, and strong acceptance in general medicine and diabetology practice when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-diabetic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.